Showing 362 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and PrEP from CROI 2023

News
15 March 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
PrEP science

HIV infections acquired while on injectable PrEP may take a very long time to be spotted

News
27 February 2023
Vaginal rings & topical PrEP

Promising new PrEP method undergoes first safety study for anal sex

News
24 February 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
Sexually transmitted infections prevention

Vaccine halves gonorrhoea rate in French study

News
20 February 2023
PrEP programmes & uptake

Preexposure Prophylaxis Gives Good Results in Latin America

Editor's pick
Medscape (requires free registration)
23 January 2023
PrEP science

Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact

News
30 December 2022
Side effects

CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention

News
27 October 2022
PrEP science

For Patients Taking PrEP, Poor Adherence Drives HIV Seroconversions

Editor's pick
Physician's Weekly
5 October 2022
New & experimental HIV treatments

Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP

News
23 September 2022
New & experimental HIV treatments

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
20 September 2022
Bone & joint problems

Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP

News
24 August 2022
Transgender people

Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds

News
11 August 2022
PrEP science

New data suggest PrEP in pregnancy is safe

News
3 August 2022
Injectable & long-acting PrEP

Injectable and long-acting PrEP A research briefing

About HIV
July 2022
Sexually transmitted infections epidemiology

Nationwide Australian data shows PrEP has largely neutral effect on STI incidence

News
15 July 2022
PrEP science

On-Demand PrEP Works as Well as Daily Pills

Editor's pick
POZ
13 July 2022
PrEP science

'Real-world' study finds PrEP may be stopping 60% of HIV infections in French men at high risk of HIV

News
29 June 2022
PrEP

Truvada or Descovy: which should I take for PrEP?

About HIV
May 2022
PrEP policies & guidelines

PrEP Can Be Cost-Effective in Sub-Saharan Africa

Editor's pick
Contagion Live
16 May 2022
PrEP science

PrEP failures (breakthrough infections)

About HIV
May 2022